PET Latest Quarter's Earnings
| Announce Date | 05/12/2025 |
| EPS Normalized Actual | $-0.1 (Miss by $-0.03) |
| EPS GAAP Actual | $-0.1 (Miss by $-0.03) |
| Revenue Actual | $0.01672B |
| Revenue Surprise | Beat by $16.72M |
Upcoming Quarter's Earnings
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.45 | 0.1 | 0.44379 | 0.45877 | 0 |
| Dec 2026 | 0.04 | 1.17 | 0.03952831 | 0.0406235 | 1 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.12 | -0.11 | 0.01672B | -11.55% | -15.18M |
| FQ1 2025 (Mar 2025) | -0.1 | -0.08 | 0.015165B | -53.11% | -15.64M |
| FQ4 2024 (Dec 2024) | 0.29 | 0.3275 | 0.015433B | -40.43% | -13.77M |
| FQ3 2024 (Sep 2024) | -0.13 | -0.06 | 0.013204B | -65.1% | -9.87M |
| FQ2 2024 (Jun 2024) | -0.055 | -1.39759 | 0.018651B | -6.27% | -20.99M |
| FQ1 2024 (Mar 2024) | -0.11 | -1.68645 | 0.023219B | 11.18% | -11.47M |
| FQ4 2023 (Dec 2023) | -0.0879 | -0.0079 | 0.021673B | 100% | 2.07M |
| FQ3 2023 (Sep 2023) | -0.0563 | 0.0237 | 0.0218B | 100% | 2.25M |
Quarterly Estimates Summary
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
2
Revenue # of Misses
6
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.01 | -0.12 | -0.11 | 91.67% |
| FQ1 2025 (Mar 2025) | -0.02 | -0.1 | -0.08 | 80% |
| FQ4 2024 (Dec 2024) | -0.0375 | 0.29 | 0.3275 | 112.93% |
| FQ3 2024 (Sep 2024) | -0.07 | -0.13 | -0.06 | 46.15% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.055 | -1.39759 | 2541.07% |
| FQ1 2024 (Mar 2024) | 1.57645 | -0.11 | -1.68645 | 1533.14% |
| FQ4 2023 (Dec 2023) | -0.08 | -0.0879 | -0.0079 | 8.99% |
| FQ3 2023 (Sep 2023) | -0.08 | -0.0563 | 0.0237 | -42.1% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.03B | $0.02B | $-15.18M | -90.79% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.02B | $-15.64M | -103.1% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.02B | $-13.77M | -89.2% |
| FQ3 2024 (Sep 2024) | $0.02B | $0.01B | $-9.87M | -74.76% |
| FQ2 2024 (Jun 2024) | $0.04B | $0.02B | $-20.99M | -112.54% |
| FQ1 2024 (Mar 2024) | $0.03B | $0.02B | $-11.47M | -49.38% |
| FQ4 2023 (Dec 2023) | $0.02B | $0.02B | $2.07M | 9.55% |
| FQ3 2023 (Sep 2023) | $0.02B | $0.02B | $2.25M | 10.32% |
PET Ratings Summary
PET Quant Ranking
